Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics Inc. | Chief Financial Officer | $1.66M | Apr 16, 2024 | ||
SNSE | Sensei Biotherapeutics, Inc. | Director | $7.59K | Jun 11, 2024 | ||
VRDN | Viridian Therapeutics, Inc.\DE | CFO and CBO | Feb 8, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|